FGF-23 in particular has recently been identified as a risk factor for VC, with several studies demonstrating correlations between elevated levels of circulating FGF-23 and increased calcification scores in CKD patients [67,68,69]. This evidence concerns the gene FGF23 and chronic kidney disease.